Eli Lilly’s Oral Obesity Pill Approved, Kicking Off Renewed Novo Rivalry
BioSpace
The FDA approved Eli Lilly's orforglipron--to be known as Foundayo--on Wednesday, officially igniting what analysts believe will be a fierce rivalry with Novo Nordisk's oral Wegovy.
pharminent
April 1, 2026 (Last updated: April 1, 2026)
BioSpace
The FDA approved Eli Lilly’s orforglipron–to be known as Foundayo–on Wednesday, officially igniting what analysts believe will be a fierce rivalry with Novo Nordisk’s oral Wegovy.
